Xinyue Wang

Key Laboratory Of Natural Medicines Of The Changbai Mountain
Longjing, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 46 publications

Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma.

Association of c-Myc and Immune Cell Infiltration in Small Cell Lung Carcinoma.

Journal: Frontiers in bioscience (Landmark edition)

Published: April 14, 2026

The oncogene c-MYC: An orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer.

The oncogene c-MYC: An orchestrator of the tumor microenvironment and drug sensitivity in small cell lung cancer.

Journal: Critical reviews in oncology/hematology

Published: November 26, 2025

Jingfang granules alleviate atopic dermatitis by restoring skin barrier function and inhibiting NF-κB/NLRP3 axis and JAK/STAT3 axis.

Jingfang granules alleviate atopic dermatitis by restoring skin barrier function and inhibiting NF-κB/NLRP3 axis and JAK/STAT3 axis.

Journal: Phytomedicine : international journal of phytotherapy and phytopharmacology

Published: November 18, 2025

Nanomedicine-Based Therapeutic Approaches in Colorectal Cancer Using Patient-Derived Xenograft Models: Prospects and Challenges.

Nanomedicine-Based Therapeutic Approaches in Colorectal Cancer Using Patient-Derived Xenograft Models: Prospects and Challenges.

Journal: International journal of nanomedicine

Published: October 12, 2025

Correction: Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91.

Correction: Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91.

Journal: Frontiers in oncology

Published: August 12, 2025

Case report: ALK inhibitor-induced transformation of ALK fusion-positive lung adenocarcinoma to large cell neuroendocrine carcinoma.

Case report: ALK inhibitor-induced transformation of ALK fusion-positive lung adenocarcinoma to large cell neuroendocrine carcinoma.

Journal: NPJ precision oncology

Published: July 24, 2025

Enzyme-driven triplex structure-based DNA logic circuits.

Enzyme-driven triplex structure-based DNA logic circuits.

Journal: Journal of nanobiotechnology

Published: June 09, 2025

A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling.

A clinically translatable 2.5D lung adenocarcinoma organoid platform derived from malignant pleural effusions for precision drug screening and tumor-immune-stromal modeling.

Journal: Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie

Published: May 05, 2025

SLC39A5 promotes the malignant progression of gastric cancer by activating BATF phosphorylation.

SLC39A5 promotes the malignant progression of gastric cancer by activating BATF phosphorylation.

Journal: The Journal of biological chemistry

Published: April 15, 2025

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91.

Cucurbitacin B inhibits HIF-1α and attenuates non-small cell lung cancer via ZFP91.

Journal: Frontiers in oncology

Published: April 07, 2025

Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC.

Mutation-guided chemotherapy-free strategy in first-line immunotherapy for low PD-L1-expressing non-squamous NSCLC.

Journal: Journal for immunotherapy of cancer

Published: November 05, 2024

SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma.

SMC4 serves as a potential marker for the diagnosis and prognosis of colon adenocarcinoma.

Journal: International journal of immunopathology and pharmacology

Published: October 18, 2024

Showing 1-12 of 46

Last Updated: 09/26/2026